Ossiam Grows Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Ossiam lifted its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 150.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,730 shares of the medical technology company's stock after buying an additional 2,241 shares during the period. Ossiam's holdings in Teleflex were worth $664,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of Teleflex during the fourth quarter valued at $1,166,000. Dimensional Fund Advisors LP boosted its position in Teleflex by 26.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 512,144 shares of the medical technology company's stock worth $91,150,000 after purchasing an additional 108,189 shares during the last quarter. Forum Financial Management LP boosted its position in Teleflex by 48.6% in the fourth quarter. Forum Financial Management LP now owns 1,293 shares of the medical technology company's stock worth $230,000 after purchasing an additional 423 shares during the last quarter. CANADA LIFE ASSURANCE Co boosted its position in Teleflex by 0.4% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 20,320 shares of the medical technology company's stock worth $3,614,000 after purchasing an additional 74 shares during the last quarter. Finally, Canada Pension Plan Investment Board boosted its position in Teleflex by 137.2% in the fourth quarter. Canada Pension Plan Investment Board now owns 22,300 shares of the medical technology company's stock worth $3,969,000 after purchasing an additional 12,900 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Price Performance

Shares of TFX stock traded down $0.58 during mid-day trading on Friday, hitting $135.08. The company had a trading volume of 678,373 shares, compared to its average volume of 631,527. Teleflex Incorporated has a 52-week low of $124.66 and a 52-week high of $249.91. The stock's 50 day moving average price is $140.16 and its 200-day moving average price is $173.49. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The company has a market capitalization of $6.26 billion, a P/E ratio of 26.85, a P/E/G ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Equities research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.01%. The ex-dividend date was Friday, March 7th. Teleflex's dividend payout ratio (DPR) is presently 95.77%.

Analyst Upgrades and Downgrades

TFX has been the topic of several research reports. Morgan Stanley dropped their target price on Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 5th. Wells Fargo & Company dropped their target price on Teleflex from $214.00 to $146.00 and set an "equal weight" rating on the stock in a research report on Friday, February 28th. Raymond James downgraded Teleflex from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. Finally, Mizuho set a $155.00 price target on shares of Teleflex in a report on Wednesday, April 16th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $169.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.